HITshow Daily: Monday, February 9, 2026
Podcast: Play in new window | Download (Duration: 8:41 — 11.9MB) | Embed
Subscribe: Spotify | Android | Podcast Index | RSS | More
Today on HITshow:
Across healthcare, the pressure is rising and starting to show. Payers warning about margins, hospitals facing new scrutiny, supply chains and digital health companies forced to prove the numbers work. Molina Healthcare shares drop sharply after weak guidance citing rising medical costs and Medicare Advantage pressure, MultiCare agrees to settlement over allegations related to unnecessary procedures, and federal lawmakers advance PBM reform legislation on transparency and oversight. Plus: Cardinal Health raises earnings outlook driven by specialty pharmaceuticals, new analysis shows 700+ hospitals nationwide at risk of closure, and Carbon Health enters Chapter 11 restructuring after struggling to reach profitability despite $3B+ valuation.
HOST: RHONDA BROOKS
📍 Finance & Capital — Logan Stokes
Molina Healthcare reported quarterly loss and projected earnings significantly below analyst expectations, citing rising medical costs, pressure in Medicare Advantage, and changes in Medicaid enrollment. Stock fell more than 25% in response, one of the sharpest reactions in payer sector in recent years. Executives pointed to utilization trends and reimbursement pressure as key drivers, reinforcing broader concerns that payer margins may tighten across government programs in 2026. Most analysts treating this as broader signal, not company-specific issue. For hospitals, could translate into tougher negotiations, slower reimbursement growth, and continued scrutiny of utilization and documentation.
📍 Strategy & Transformation — Teresa Vaughn
MultiCare agreed to settlement tied to allegations that some procedures were performed without sufficient medical necessity. While the organization did not admit wrongdoing, the case highlights increasing scrutiny from regulators and payers around utilization, documentation, and peer review processes. Many hospitals expanding clinical analytics and utilization review programs to identify outliers earlier and reduce risk before it becomes legal or compliance issue.
📍 Healthcare Policy & Advocacy — Xavier Banks
Federal lawmakers advanced legislation aimed at increasing transparency and oversight of pharmacy benefit managers. Proposals focus on pricing practices, rebate structures, and reporting requirements. For hospitals and health systems, changes in PBM practices could influence specialty drug purchasing, reimbursement dynamics, and employer-driven coverage decisions. Most analysts say effects would be gradual, but even incremental changes in drug pricing transparency could shift negotiations within a year or two.
📍 Finance & Capital — Peter Betterworth
Cardinal Health reported stronger-than-expected results and raised full-year earnings guidance, driven largely by growth in specialty pharmaceuticals and strong distribution performance. Executives pointed to sustained demand for high-cost therapies and continued pressure on healthcare supply chains to manage cost and inventory efficiently. Specialty pharmaceuticals continue to grow as share of spending—where much of financial pressure and opportunity is concentrating.
📍 Strategy & Transformation — Teresa Vaughn
A recent report finds more than 700 hospitals nationwide considered at risk of closure, with hundreds facing immediate financial vulnerability. Many are rural or safety-net providers where labor costs, payer mix, and declining volumes have strained margins. Trend contributing to consolidation, service reductions, and growing concern about access to care in certain regions. Some systems improving margins, but for smaller hospitals, workforce costs and reimbursement remain major challenges.
📍 Digital Health — Nate Collier
Carbon Health, once valued at more than $3B and seen as leader in hybrid virtual-and-in-person care, entered Chapter 11 restructuring after struggling to reach profitability. The trajectory reflects broader shift in digital health where investors and health systems now demand clear evidence of ROI, sustainable margins, and integration with clinical workflows. For hospital executives evaluating vendors: long-term viability now matters as much as innovation. Investment shifting toward companies demonstrating measurable outcomes and operational value.
🎙️ Subscribe here or wherever you listen to podcasts, and if you like our show, please follow us on LinkedIn at https://www.linkedin.com/company/hit_show.
